NCT05868967

A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 8 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the Mass Balance and Biotransformation of \[14C\]DWP14012 in Healthy Chinese Male Subjects

Detailed description

This study is a single-center, single-dose, non-randomized, open-label design with two parts. Each subject will receive a single oral dose of \[14C\]DWP14012 suspension (containing approximately 40 mg/80 μCi \[14C\]DWP14012) under the fasting conditions

Conditions

• Phase 1 Study, Healthy Volunteers

Interventions

Type	Name	Description
DRUG	[14C]DWP14012	Each subject will receive a single oral dose of \[14C\]DWP14012 suspension (containing approximately 40 mg/80 μCi \[14C\]DWP14012) under fasting conditions.

Timeline

• Start date: 2023-02-27
• Primary completion: 2023-05-31
• Completion: 2023-10-31
• First posted: 2023-05-22
• Last updated: 2023-05-22

Locations

1 site across 1 country: China